From - Diagnostic Testing & Emerging Technologies
As the price of sequencing continues to drop and genomic testing in oncology continues to shift towards larger panels, physicians have self-reported difficulty in…
From - Diagnostic Testing & Emerging Technologies
The United States is falling behind national goals to identify patients unaware of their positive HIV status and link them to care…
From - Diagnostic Testing & Emerging Technologies
In what is being heralded a major milestone for personalized medicine, in late May the U.S. Food and Drug Administration (FDA) approved the first…
From - Diagnostic Testing & Emerging Technologies
Televised direct-to-consumer advertising (DTCA) is associated with greater testosterone testing, according to a study published March 21 in the Journal of the American Medical Association…